Vivus asks for weight-loss drug approval in Europe Bloomberg (AP) — Vivus Inc. said Monday it asked European regulators to approve its weight-loss drug Qnexa, which has already been rejected by US regulators because ... Vivus Files Application For Weight Loss Drug (VVUS) Benzinga Vivus Files European Market Application For Diet Pill Qnexa Wall Street Journal VIVUS Files European Marketing Authorization Application for QNEXA® in the ... Read more »
Vivus Files Application For Weight Loss Drug (VVUS) – Benzinga
Vivus Files Application For Weight Loss Drug (VVUS) Benzinga Qnexa is being developed to address weight loss , type 2 diabetes and obstructive sleep apnea. If approved, Qnexa could be recommended for obese or ... Vivus Files European Market Application For Diet Pill Qnexa Wall Street Journal VIVUS Files European Marketing Authorization Application for QNEXA® in the ... Read more »
VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results – MarketWatch (press release)
VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results MarketWatch (press release) On September 21, 2010, we announced top-line results from a two-year study of Qnexa which showed significant and sustained weight loss of greater than 10% ... Vivus narrows Q3 loss to $18M Bizjournals.com all 42 news articles?? Read more »
FDA Rejects Weight Loss Drug Qnexa – Food Consumer
Health Jackal FDA Rejects Weight Loss Drug Qnexa Food Consumer New reports say the Food and Drug Administration has rejected Vivus Inc's petition for an approval to market a prescription weight loss drug called Qnexa in ... Weight-loss drug Qnexa is denied approval Los Angeles Times Vivus shares rise on optimism for weight-loss drug BusinessWeek Vivus Shares Rise 26%, Investors Hopeful Of FDA Approval For Weight Loss Pill Visit Bulgaria Reuters ?- Reporters Live! ?- Health Jackal all 559 news articles?? Read more »
Vivus still confident in their weight loss drug Qnexa – Health Jackal
Washington Post Vivus still confident in their weight loss drug Qnexa Health Jackal The Food and Drug Administration (FDA) on Thursday rejected the approval of the Vivus' prescription weight-loss drug Qnexa. Although FDA officials have said ... Weight-loss drug Qnexa is denied approval Los Angeles Times Vivus shares rise on optimism for weight-loss drug BusinessWeek Vivus shares soar on weight loss drug optimism Reuters HealthNews ?- The Epoch Times ?- Mediapost.com all 540 news articles?? Read more »
Weight-loss drug Qnexa is denied approval – Baltimore Sun
Washington Post Weight-loss drug Qnexa is denied approval Baltimore Sun The Food and Drug Administration on Thursday declined to approve the prescription weight-loss drug Qnexa. .. Read more »
After Rejecting Lorcaserin, FDA Thumbs down Weight Loss Drug Qnexa – All247News
Washington Post After Rejecting Lorcaserin, FDA Thumbs down Weight Loss Drug Qnexa All247News The US Food and Drug Administration has turned down experimental weight loss drug Qnexa in its present form, the drug's manufacturer Vivus Inc. ... Read more »
FDA Rejects Qnexa, a Third Weight-Loss Drug – New York Times
WISC Madison FDA Rejects Qnexa, a Third Weight-Loss Drug New York Times The rejected drug, called Qnexa, is the third weight loss medicine to run into trouble this month because of concerns about safety. .. Read more »
Is There Still Hope for the Weight Loss Drug Qnexa? – TIME
Is There Still Hope for the Weight Loss Drug Qnexa? TIME This follows medical guidelines that major weight loss is more effective when it happens slowly. Read more »
Vivus hammered on panel’s view on weight-loss drug – MarketWatch
Vivus hammered on panel's view on weight-loss drug MarketWatch ... advisory panel late Thursday recommended a rejection of weight-loss drug Qnexa by a 9-to-7 vote on worries of a lack of long-term safety data. Read more »
